Speakers
Dr Sarah Davies GP with a Special Interest in Diabetes, Cardiff
Professor Ketan Dhatariya Consultant in Diabetes and Endocrinology, Honorary Professor of Medicine, Norwich
Learning objectives
-
- To look at the causes of type 2 diabetes, its metabolic comorbidities and long-term complications
- To consider the evolution of the management of type 2 diabetes from a glucose-centric approach to adopting a CVRM approach
- To examine the importance of early diagnosis of type 2 diabetes and some of the challenges patients face following diagnosis
Learning module instructions
This BJC TV Learning module has a recommended award of 1 CPD credit for completion (1 hour of learning).
Completion requires a score of at least 80%. If less time is spent learning, then you should claim a reduced credit value.
After you have successfully completed the test you will be able to download your certificate.
Quiz Summary
0 of 6 Questions completed
Questions:
Information
You have already completed the quiz before. Hence you can not start it again.
Quiz is loading…
You must sign in or sign up to start the quiz.
You must first complete the following:
Results
Results
0 of 6 Questions answered correctly
Your time:
Time has elapsed
You have reached 0 of 0 point(s), (0)
Earned Point(s): 0 of 0, (0)
0 Essay(s) Pending (Possible Point(s): 0)
Categories
-
Not categorized
0%
- 1
- 2
- 3
- 4
- 5
- 6
-
Current -
Review -
Answered -
Correct -
Incorrect
-
Question 1 of 6
1. Question
1. What percentage of people die within one year of hospitalisation for heart failure? Please select the correct answer.
Correct
Incorrect -
-
Question 2 of 6
2. Question
2. What are the diagnostic criteria for heart failure with mildly reduced ejection fraction (HFmrEF)? Please select the correct answer.
Correct
Incorrect -
-
Question 3 of 6
3. Question
3. According to the recommendations in the ESC guidelines3, which of the following blood tests would you use to evaluate for possible aggravating factors and/or alternative diagnoses to heart failure? Please select all answers that apply.
Correct
Incorrect -
-
Question 4 of 6
4. Question
4. According to the ESC algorithm for class I therapy treatment strategies for patients with heart failure with reduced ejection fraction (HFrEF), what are the class I-recommended agents? Please select all answers that apply.
Correct
Incorrect -
-
Question 5 of 6
5. Question
5. According to the New York Heart Association (NYHA) symptom-based severity classification system for chronic heart failure, what class would a patient fall into if they presented with and of the following symptoms: marked limitation of physical activity, comfortable at rest, less than ordinary activity causes fatigue, palpitations, or dyspnoea? Please select the correct answer.
Correct
Incorrect -
-
Question 6 of 6
6. Question
6. In a cross-trial analysis, a newer comprehensive pharmacological treatment regimen for heart failure (ARNI+ beta-blocker + MRA + SGLT2-I) has been shown to reduce the incidence of CV death or first hospitalisation compared to the older conventional therapy options (ACEI/ARB + beta-blocker)5. According to Vaduganathan M and colleagues (2020), how many additional years free from CV death or first hospitalisation did the comprehensive therapy option give compared to the conventional therapy for a 55-year-old? Please select the correct answer.
Correct
Incorrect -
References
1. Taylor CJ et al. BMJ 2019;364:I223. https://doi.org/10.1136/bmj.l223
2. McDonagh TA et al. Eur Heart J 2023;44(37):3627–3639. https://doi.org/10.1093/eurheartj/ehad195
3. McDonagh TA et al. Eur Heart J 2021;42:3599–3726. https://doi.org/10.1093/eurheartj/ehab368
4. Yancy CW et al. Circulation 2013;128:e240–e327. https://doi.org/10.1161/CIR.0b013e31829e8776
5. Vaduganathan M et al. Lancet 2020;396:121–128. https://doi.org/10.1016/S0140-6736(20)30748-0